Skip to content

    Hindustan Unilever Q4 FY25 earnings call

    HINDUNILVR
    Fast Moving Consumer Goods·24 Apr 2025
    Management Summary

    Hindustan Unilever Limited reported a challenging FY25 with 2% underlying sales and volume growth amidst subdued demand, particularly in urban areas. Gross and EBITDA margins saw slight compression due to commodity inflation and strategic investments. However, the company is aggressively transforming its portfolio, investing in high-growth segments like Market Makers and Channels of the Future, and relaunching core brands, expecting a gradual demand recovery and improved performance in H1 FY26 while maintaining EBITDA in the 22-23% range.

    Highlights

    5
    • FY25 Underlying Sales Growth (USG) and Underlying Volume Growth (UVG) both at 2%, demonstrating competitive growth.

    • Q4 FY25 USG at 3% and UVG at 2%, showing sequential improvement.

    • Total dividend for FY25 declared at ₹53 per share, including a special dividend, marking a 26% YoY increase.

    • Market Makers portfolio delivered double-digit growth, with Ponds showing double-digit USG and OZiva's annual revenue run rate scaling from ₹100 crores to ₹400 crores, achieving profitability.

    • Channels of the Future delivered strong competitive growth, with e-commerce gross sales value growing circa 40%.

    Concerns

    5
    • FY25 Gross Margin at 50.3%, down 50 bps YoY, primarily due to business mix and increased investments.

    • FY25 EBITDA margin at 23.5%, lower by 30 bps YoY, and Q4 FY25 EBITDA margin at 23.1%, lower by 30 bps YoY.

    • Q4 FY25 Gross Margin at 49.8%, lower by 160 bps YoY, driven by commodity inflation in Palm oil, Tea, and Coffee not fully priced for.

    • FY25 Personal Care (Skin Cleansing) USG declined by 3% with a low single-digit decline in UVG.

    • Q4 FY25 Foods turnover declined by 1%, with Nutrition Drinks declining due to category headwinds and pack price architecture changes.

    Key financials

    Metrics

    11

    Periods

    2

    Q4 FY25

    5
    • Underlying Sales Growth
      3%
    • Underlying Volume Growth
      2%
    • Gross Margin
      49.8%
      YoY-1.6%
    • EBITDA Margin
      23.1%
      YoY-0.3%
    • PAT
      YoY+4%

    FY25

    6
    • Turnover
      ₹60,680 Cr
    • Underlying Sales Growth
      2%
    • Underlying Volume Growth
      2%
    • Gross Margin
      50.3%
      YoY-0.5%
    • EBITDA Margin
      23.5%
      YoY-0.3%

    Segment breakdown

    Home Care (FY25)
    5% USG8% UVG19% Margin
    Beauty & Wellbeing (FY25)
    2% USG32% Margin
    Personal Care (FY25)
    -3% USG-2% UVG18% Margin
    Foods (FY25)
    0% Turnover Growth-2% Volume Growth18% Margin
    Home Care (Q4 FY25)
    3% USG5% Volume Growth
    Beauty & Wellbeing (Q4 FY25)
    3% USG
    Personal Care (Q4 FY25)
    3% USG
    Foods (Q4 FY25)
    -1% Turnover Growth
    List

    Capital allocation

    7
    high confidence
    CategoryHeadline
    Dividend

    ₹24/share (final)

    M&A

    OZiva

    acquisition · integrated

    M&A

    Minimalist

    acquisition · closed

    M&A

    Pureit

    divestment · closed · Consideration ₹600 crores

    M&A

    Ice cream business

    divestment · pending regulatory

    Guidance & targets

    8
    CategoryTargetPriority
    Growth
    Growth trends
    H1 FY26 better than H2 FY25
    High
    Growth
    Volume-led competitive growth
    focus
    High
    Profitability
    Price growth
    low-single digit range
    Medium
    Profitability
    Gross margin
    moderate further
    Medium
    Profitability
    EBITDA Margin
    22% to 23%
    High
    Market Share
    Market share
    increase
    High
    Segment Performance
    Home Care USG
    negative
    High
    Segment Performance
    Skin Cleansing price actions
    appropriate pricing actions
    High

    What to watch in Q1 FY26

    5

    Overall Demand Improvement

    Next quarter (June quarter, September quarter)
    CurrentSubdued, urban moderating, rural improving gradually
    TargetGradual improvement, H1 FY26 better than H2 FY25

    Why it matters

    Key driver for volume growth and overall business performance, indicating macro recovery.

    In this context, we expect first half of financial year '26 to be better than second half of financial year '25.

    Risks & concerns

    4
    RiskSeverity

    Commodity Inflation

    Significant inflation observed in palm oil, tea, and coffee, leading to gross margin moderation in Q4 FY25 and expected to continue in the near term.Management acknowledged

    medium

    Subdued Demand Trends

    FMCG market witnessed subdued demand in FY25, with urban demand moderating, though rural demand is gradually improving.Management acknowledged

    medium

    Nutrition Drinks Category Headwinds

    Nutrition Drinks declined in Q4 FY25 due to category headwinds and transitional impact of pack price architecture changes.Management acknowledged

    medium

    Price-Value Equation Adjustments

    Calibrated price increases in some segments were offset by price reductions in others, and gross margin was impacted by commodity inflation not fully priced for.Management acknowledged

    medium

    Q&A highlights

    8

    “So, the entire EBITDA change that we intend to do, which is basically moving from the lower end of the 23%-24% range, which we had mentioned in the previous quarter to 22%-23%, is essentially not price versus cost adjustment. The Intention behind this change is to dial up Investments across all the lines of the P&L.”

    Clarified that the 100 bps moderation in EBITDA guidance is a strategic choice to invest for growth across the P&L, not a price-cost issue, with a focus on Beauty & Wellbeing.

    asked by Avi from Macquarie

    2 min read6 chapters

    Detailed Narrative

    01

    FY25 Performance and Market Dynamics

    Hindustan Unilever Limited concluded FY25 with a turnover of ₹60,680 crores, achieving 2% underlying sales growth and 2% underlying volume growth. The FMCG market faced subdued demand, characterized by gradual rural improvement and urban moderation. Gross margin for the year stood at 50.3%, a 50 bps decline YoY, while EBITDA was 23.5%, down 30 bps YoY, primarily influenced by business mix and increased investments across distribution channels. PAT grew 5% YoY, benefiting from the Pureit divestment.

    02

    Strategic Portfolio Transformation and Brand Relaunches

    The company is executing a strategic portfolio transformation, shifting 200 basis points from Core to Future Core and Market Makers segments, aiming for over 80% of growth from these high-potential areas. Key initiatives included the comprehensive 6P relaunch of core brands Lifebuoy and Glow & Lovely to meet evolving consumer needs. The Future Core portfolio delivered competitive value and volume growth, and the Market Makers portfolio achieved double-digit growth, exemplified by Ponds' double-digit USG.

    03

    Channels of the Future and Digital Acceleration

    HUL is intensifying its focus on Channels of the Future, with e-commerce contributing circa 40% gross sales value growth and quick commerce, though 2% of the business, growing rapidly. Investments include doubling assortment and enhancing availability in quick commerce. Digital media spends have been accelerated, with influencer marketing increasing by approximately 40%, to drive social-first demand generation and improve on-shelf and online availability by 200 and 500 basis points, respectively.

    04

    M&A and Portfolio Sharpening Initiatives

    The company completed the acquisition of a 90.5% stake in Minimalist, which recorded over ₹500 crores turnover in FY25. OZiva, acquired in 2023, scaled its annual revenue run rate from ₹100 crores to ₹400 crores and achieved profitability, moving from a 40-50% EBITDA loss to breaking even. The divestment of Pureit unlocked circa ₹600 crores, and the demerger of the Ice Cream business is progressing, expected to be completed by the end of FY26, alongside strategic investments in palm localization and plastic circularity.

    05

    Nutrition Drinks Turnaround Strategy

    The Nutrition Drinks segment faced headwinds in Q4 FY25, leading to a decline in performance. HUL plans a three-pronged strategy to boost consumption: revitalizing Horlicks for contemporary relevance, doubling down on the ₹500 crore Adult Nutrition business through medical marketing and chemist engagement, and expanding the Boost brand into new regions and ready-to-drink formats. Management emphasized that margins are healthy in this category, providing ample scope for investment to drive growth.

    06

    Outlook and Investment-Led Growth Strategy

    HUL projects a gradual improvement in growth trends, with H1 FY26 expected to outperform H2 FY25, driven by positive macroeconomic factors like a normal monsoon, monetary stimulus, and lower inflation. Despite commodity inflation, the company plans to maintain EBITDA margins in the 22-23% range for the next 2-3 quarters by strategically increasing investments across the P&L, including trade channels, product quality, and A&P, to prioritize volume-led competitive growth and strengthen market leadership.

    This is an AI-generated summary of a publicly available earnings call transcript.